nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—breast cancer—ovarian cancer	0.306	1	CtDrD
Vinorelbine—TUBB3—ovarian cancer	0.209	0.886	CbGaD
Vinorelbine—ABCB1—ovarian cancer	0.0267	0.114	CbGaD
Vinorelbine—TUBB2B—Paclitaxel—ovarian cancer	0.0222	0.0662	CbGbCtD
Vinorelbine—TUBB6—Paclitaxel—ovarian cancer	0.0222	0.0662	CbGbCtD
Vinorelbine—TUBB2A—Paclitaxel—ovarian cancer	0.0222	0.0662	CbGbCtD
Vinorelbine—TUBB3—Paclitaxel—ovarian cancer	0.0222	0.0662	CbGbCtD
Vinorelbine—TUBB8—Paclitaxel—ovarian cancer	0.0222	0.0662	CbGbCtD
Vinorelbine—TUBB4A—Paclitaxel—ovarian cancer	0.0222	0.0662	CbGbCtD
Vinorelbine—TUBB4B—Paclitaxel—ovarian cancer	0.0186	0.0554	CbGbCtD
Vinorelbine—TUBB—Paclitaxel—ovarian cancer	0.0186	0.0554	CbGbCtD
Vinorelbine—TUBB1—Paclitaxel—ovarian cancer	0.0186	0.0554	CbGbCtD
Vinorelbine—TUBB2B—Docetaxel—ovarian cancer	0.0161	0.0479	CbGbCtD
Vinorelbine—TUBB2A—Docetaxel—ovarian cancer	0.0161	0.0479	CbGbCtD
Vinorelbine—TUBB4A—Docetaxel—ovarian cancer	0.0161	0.0479	CbGbCtD
Vinorelbine—TUBB3—Docetaxel—ovarian cancer	0.0161	0.0479	CbGbCtD
Vinorelbine—TUBB6—Docetaxel—ovarian cancer	0.0161	0.0479	CbGbCtD
Vinorelbine—TUBB8—Docetaxel—ovarian cancer	0.0161	0.0479	CbGbCtD
Vinorelbine—TUBB1—Docetaxel—ovarian cancer	0.0135	0.0401	CbGbCtD
Vinorelbine—TUBB4B—Docetaxel—ovarian cancer	0.0135	0.0401	CbGbCtD
Vinorelbine—TUBB—Docetaxel—ovarian cancer	0.0135	0.0401	CbGbCtD
Vinorelbine—ABCB1—Topotecan—ovarian cancer	0.00268	0.00797	CbGbCtD
Vinorelbine—CYP3A4—Topotecan—ovarian cancer	0.0016	0.00477	CbGbCtD
Vinorelbine—ABCB1—Paclitaxel—ovarian cancer	0.00132	0.00394	CbGbCtD
Vinorelbine—TUBB4B—oviduct—ovarian cancer	0.00131	0.0525	CbGeAlD
Vinorelbine—ABCB1—Docetaxel—ovarian cancer	0.000958	0.00285	CbGbCtD
Vinorelbine—Vinblastine—NR5A1—ovarian cancer	0.000855	0.401	CrCbGaD
Vinorelbine—CYP3A4—Paclitaxel—ovarian cancer	0.000794	0.00236	CbGbCtD
Vinorelbine—ABCB1—Doxorubicin—ovarian cancer	0.000714	0.00213	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—ovarian cancer	0.000673	0.002	CbGbCtD
Vinorelbine—TUBB1—decidua—ovarian cancer	0.000641	0.0257	CbGeAlD
Vinorelbine—TUBB8—testis—ovarian cancer	0.000609	0.0244	CbGeAlD
Vinorelbine—CYP3A4—Docetaxel—ovarian cancer	0.000574	0.00171	CbGbCtD
Vinorelbine—TUBB2B—myometrium—ovarian cancer	0.00052	0.0208	CbGeAlD
Vinorelbine—TUBB4A—embryo—ovarian cancer	0.000517	0.0207	CbGeAlD
Vinorelbine—TUBB—myometrium—ovarian cancer	0.000492	0.0197	CbGeAlD
Vinorelbine—Vinblastine—TUBB3—ovarian cancer	0.000491	0.231	CrCbGaD
Vinorelbine—TUBB2A—myometrium—ovarian cancer	0.000489	0.0196	CbGeAlD
Vinorelbine—Vincristine—TUBB3—ovarian cancer	0.000483	0.227	CrCbGaD
Vinorelbine—TUBB6—myometrium—ovarian cancer	0.000483	0.0193	CbGeAlD
Vinorelbine—TUBB1—bone marrow—ovarian cancer	0.000476	0.0191	CbGeAlD
Vinorelbine—CYP3A4—Doxorubicin—ovarian cancer	0.000428	0.00127	CbGbCtD
Vinorelbine—TUBB4B—myometrium—ovarian cancer	0.000419	0.0168	CbGeAlD
Vinorelbine—TUBB4A—uterine cervix—ovarian cancer	0.000418	0.0168	CbGeAlD
Vinorelbine—TUBB3—testis—ovarian cancer	0.000416	0.0167	CbGeAlD
Vinorelbine—TUBB1—testis—ovarian cancer	0.000407	0.0163	CbGeAlD
Vinorelbine—TUBB2B—uterine cervix—ovarian cancer	0.000404	0.0162	CbGeAlD
Vinorelbine—TUBB4B—embryo—ovarian cancer	0.000403	0.0162	CbGeAlD
Vinorelbine—TUBB—uterine cervix—ovarian cancer	0.000383	0.0153	CbGeAlD
Vinorelbine—TUBB2A—uterine cervix—ovarian cancer	0.000381	0.0152	CbGeAlD
Vinorelbine—TUBB6—epithelium—ovarian cancer	0.000379	0.0152	CbGeAlD
Vinorelbine—TUBB6—uterine cervix—ovarian cancer	0.000376	0.015	CbGeAlD
Vinorelbine—TUBB2B—endometrium—ovarian cancer	0.000366	0.0147	CbGeAlD
Vinorelbine—TUBB—decidua—ovarian cancer	0.000365	0.0146	CbGeAlD
Vinorelbine—TUBB2A—decidua—ovarian cancer	0.000363	0.0145	CbGeAlD
Vinorelbine—TUBB6—decidua—ovarian cancer	0.000358	0.0143	CbGeAlD
Vinorelbine—TUBB4A—gonad—ovarian cancer	0.000351	0.0141	CbGeAlD
Vinorelbine—TUBB4A—uterus—ovarian cancer	0.000349	0.014	CbGeAlD
Vinorelbine—TUBB—endometrium—ovarian cancer	0.000346	0.0139	CbGeAlD
Vinorelbine—TUBB2A—endometrium—ovarian cancer	0.000344	0.0138	CbGeAlD
Vinorelbine—TUBB6—endometrium—ovarian cancer	0.00034	0.0136	CbGeAlD
Vinorelbine—TUBB2B—gonad—ovarian cancer	0.000339	0.0136	CbGeAlD
Vinorelbine—TUBB4B—uterine cervix—ovarian cancer	0.000326	0.0131	CbGeAlD
Vinorelbine—TUBB—uterus—ovarian cancer	0.000319	0.0128	CbGeAlD
Vinorelbine—TUBB2A—uterus—ovarian cancer	0.000317	0.0127	CbGeAlD
Vinorelbine—TUBB6—gonad—ovarian cancer	0.000315	0.0126	CbGeAlD
Vinorelbine—TUBB4A—female reproductive system—ovarian cancer	0.000314	0.0126	CbGeAlD
Vinorelbine—TUBB6—uterus—ovarian cancer	0.000313	0.0125	CbGeAlD
Vinorelbine—TUBB4B—decidua—ovarian cancer	0.000311	0.0125	CbGeAlD
Vinorelbine—TUBB2B—female reproductive system—ovarian cancer	0.000303	0.0121	CbGeAlD
Vinorelbine—TUBB4B—endometrium—ovarian cancer	0.000295	0.0118	CbGeAlD
Vinorelbine—TUBB4A—female gonad—ovarian cancer	0.000285	0.0114	CbGeAlD
Vinorelbine—TUBB2A—female reproductive system—ovarian cancer	0.000285	0.0114	CbGeAlD
Vinorelbine—TUBB6—female reproductive system—ovarian cancer	0.000281	0.0113	CbGeAlD
Vinorelbine—TUBB2B—female gonad—ovarian cancer	0.000276	0.011	CbGeAlD
Vinorelbine—TUBB2B—vagina—ovarian cancer	0.000274	0.011	CbGeAlD
Vinorelbine—TUBB4B—gonad—ovarian cancer	0.000274	0.011	CbGeAlD
Vinorelbine—TUBB4B—uterus—ovarian cancer	0.000272	0.0109	CbGeAlD
Vinorelbine—TUBB—bone marrow—ovarian cancer	0.000271	0.0108	CbGeAlD
Vinorelbine—TUBB2A—bone marrow—ovarian cancer	0.000269	0.0108	CbGeAlD
Vinorelbine—TUBB6—bone marrow—ovarian cancer	0.000266	0.0106	CbGeAlD
Vinorelbine—TUBB—female gonad—ovarian cancer	0.000261	0.0105	CbGeAlD
Vinorelbine—TUBB2A—female gonad—ovarian cancer	0.00026	0.0104	CbGeAlD
Vinorelbine—TUBB—vagina—ovarian cancer	0.000259	0.0104	CbGeAlD
Vinorelbine—TUBB2A—vagina—ovarian cancer	0.000258	0.0103	CbGeAlD
Vinorelbine—TUBB6—female gonad—ovarian cancer	0.000256	0.0103	CbGeAlD
Vinorelbine—TUBB6—vagina—ovarian cancer	0.000254	0.0102	CbGeAlD
Vinorelbine—TUBB4A—testis—ovarian cancer	0.000253	0.0101	CbGeAlD
Vinorelbine—TUBB2B—testis—ovarian cancer	0.000245	0.0098	CbGeAlD
Vinorelbine—TUBB4B—female reproductive system—ovarian cancer	0.000245	0.0098	CbGeAlD
Vinorelbine—TUBB—testis—ovarian cancer	0.000231	0.00927	CbGeAlD
Vinorelbine—TUBB4B—bone marrow—ovarian cancer	0.000231	0.00925	CbGeAlD
Vinorelbine—TUBB2A—testis—ovarian cancer	0.00023	0.00922	CbGeAlD
Vinorelbine—TUBB6—testis—ovarian cancer	0.000227	0.00909	CbGeAlD
Vinorelbine—TUBB4B—female gonad—ovarian cancer	0.000223	0.00891	CbGeAlD
Vinorelbine—TUBB4B—vagina—ovarian cancer	0.000221	0.00886	CbGeAlD
Vinorelbine—TUBB4B—testis—ovarian cancer	0.000197	0.00791	CbGeAlD
Vinorelbine—TUBB4A—lymph node—ovarian cancer	0.000183	0.00735	CbGeAlD
Vinorelbine—TUBB2B—lymph node—ovarian cancer	0.000177	0.0071	CbGeAlD
Vinorelbine—Voacamine—ABCB1—ovarian cancer	0.000176	0.0828	CrCbGaD
Vinorelbine—TUBB—lymph node—ovarian cancer	0.000168	0.00672	CbGeAlD
Vinorelbine—TUBB2A—lymph node—ovarian cancer	0.000167	0.00668	CbGeAlD
Vinorelbine—TUBB6—lymph node—ovarian cancer	0.000165	0.00659	CbGeAlD
Vinorelbine—TUBB4B—lymph node—ovarian cancer	0.000143	0.00573	CbGeAlD
Vinorelbine—ABCB1—myometrium—ovarian cancer	0.000122	0.00489	CbGeAlD
Vinorelbine—ABCB1—embryo—ovarian cancer	0.000117	0.0047	CbGeAlD
Vinorelbine—CYP3A4—female reproductive system—ovarian cancer	0.0001	0.00402	CbGeAlD
Vinorelbine—CYP2D6—female reproductive system—ovarian cancer	9.89e-05	0.00396	CbGeAlD
Vinorelbine—ABCB1—epithelium—ovarian cancer	9.58e-05	0.00384	CbGeAlD
Vinorelbine—ABCB1—uterine cervix—ovarian cancer	9.49e-05	0.0038	CbGeAlD
Vinorelbine—ABCB1—decidua—ovarian cancer	9.05e-05	0.00362	CbGeAlD
Vinorelbine—CYP2D6—female gonad—ovarian cancer	9e-05	0.0036	CbGeAlD
Vinorelbine—ABCB1—endometrium—ovarian cancer	8.59e-05	0.00344	CbGeAlD
Vinorelbine—CYP2D6—testis—ovarian cancer	7.98e-05	0.0032	CbGeAlD
Vinorelbine—ABCB1—gonad—ovarian cancer	7.96e-05	0.00319	CbGeAlD
Vinorelbine—ABCB1—uterus—ovarian cancer	7.91e-05	0.00317	CbGeAlD
Vinorelbine—ABCB1—female reproductive system—ovarian cancer	7.11e-05	0.00285	CbGeAlD
Vinorelbine—ABCB1—bone marrow—ovarian cancer	6.72e-05	0.00269	CbGeAlD
Vinorelbine—ABCB1—female gonad—ovarian cancer	6.47e-05	0.00259	CbGeAlD
Vinorelbine—ABCB1—vagina—ovarian cancer	6.43e-05	0.00258	CbGeAlD
Vinorelbine—Vinblastine—ABCB1—ovarian cancer	6.3e-05	0.0296	CrCbGaD
Vinorelbine—Vincristine—ABCB1—ovarian cancer	6.19e-05	0.0291	CrCbGaD
Vinorelbine—ABCB1—testis—ovarian cancer	5.74e-05	0.0023	CbGeAlD
Vinorelbine—Dermatitis bullous—Doxorubicin—ovarian cancer	4.24e-05	0.000665	CcSEcCtD
Vinorelbine—Angioedema—Paclitaxel—ovarian cancer	4.22e-05	0.000661	CcSEcCtD
Vinorelbine—Flushing—Docetaxel—ovarian cancer	4.17e-05	0.000654	CcSEcCtD
Vinorelbine—Cardiac disorder—Docetaxel—ovarian cancer	4.17e-05	0.000654	CcSEcCtD
Vinorelbine—Vomiting—Topotecan—ovarian cancer	4.16e-05	0.000653	CcSEcCtD
Vinorelbine—Malaise—Paclitaxel—ovarian cancer	4.16e-05	0.000653	CcSEcCtD
Vinorelbine—ABCB1—lymph node—ovarian cancer	4.16e-05	0.00167	CbGeAlD
Vinorelbine—Cardiac failure—Doxorubicin—ovarian cancer	4.15e-05	0.000651	CcSEcCtD
Vinorelbine—Vertigo—Paclitaxel—ovarian cancer	4.15e-05	0.00065	CcSEcCtD
Vinorelbine—Lethargy—Doxorubicin—ovarian cancer	4.14e-05	0.000649	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Doxorubicin—ovarian cancer	4.14e-05	0.000649	CcSEcCtD
Vinorelbine—Leukopenia—Paclitaxel—ovarian cancer	4.13e-05	0.000648	CcSEcCtD
Vinorelbine—Rash—Topotecan—ovarian cancer	4.13e-05	0.000647	CcSEcCtD
Vinorelbine—Dermatitis—Topotecan—ovarian cancer	4.12e-05	0.000647	CcSEcCtD
Vinorelbine—Blood creatinine increased—Epirubicin—ovarian cancer	4.1e-05	0.000644	CcSEcCtD
Vinorelbine—Headache—Topotecan—ovarian cancer	4.1e-05	0.000643	CcSEcCtD
Vinorelbine—Palpitations—Paclitaxel—ovarian cancer	4.08e-05	0.00064	CcSEcCtD
Vinorelbine—Angiopathy—Docetaxel—ovarian cancer	4.08e-05	0.000639	CcSEcCtD
Vinorelbine—Vomiting—Melphalan—ovarian cancer	4.08e-05	0.000639	CcSEcCtD
Vinorelbine—Hyponatraemia—Doxorubicin—ovarian cancer	4.07e-05	0.000638	CcSEcCtD
Vinorelbine—Immune system disorder—Docetaxel—ovarian cancer	4.06e-05	0.000636	CcSEcCtD
Vinorelbine—Mediastinal disorder—Docetaxel—ovarian cancer	4.05e-05	0.000635	CcSEcCtD
Vinorelbine—Rash—Melphalan—ovarian cancer	4.04e-05	0.000634	CcSEcCtD
Vinorelbine—Dermatitis—Melphalan—ovarian cancer	4.04e-05	0.000633	CcSEcCtD
Vinorelbine—Cough—Paclitaxel—ovarian cancer	4.03e-05	0.000632	CcSEcCtD
Vinorelbine—Arrhythmia—Docetaxel—ovarian cancer	4.01e-05	0.000629	CcSEcCtD
Vinorelbine—Hypertension—Paclitaxel—ovarian cancer	3.98e-05	0.000625	CcSEcCtD
Vinorelbine—Alopecia—Docetaxel—ovarian cancer	3.97e-05	0.000623	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	3.94e-05	0.000619	CcSEcCtD
Vinorelbine—Chest pain—Paclitaxel—ovarian cancer	3.93e-05	0.000616	CcSEcCtD
Vinorelbine—Myalgia—Paclitaxel—ovarian cancer	3.93e-05	0.000616	CcSEcCtD
Vinorelbine—Arthralgia—Paclitaxel—ovarian cancer	3.93e-05	0.000616	CcSEcCtD
Vinorelbine—Malnutrition—Docetaxel—ovarian cancer	3.91e-05	0.000613	CcSEcCtD
Vinorelbine—Erythema—Docetaxel—ovarian cancer	3.91e-05	0.000613	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	3.9e-05	0.000612	CcSEcCtD
Vinorelbine—Nausea—Topotecan—ovarian cancer	3.89e-05	0.00061	CcSEcCtD
Vinorelbine—Discomfort—Paclitaxel—ovarian cancer	3.88e-05	0.000609	CcSEcCtD
Vinorelbine—Muscular weakness—Epirubicin—ovarian cancer	3.86e-05	0.000606	CcSEcCtD
Vinorelbine—Nausea—Melphalan—ovarian cancer	3.81e-05	0.000597	CcSEcCtD
Vinorelbine—Blood creatinine increased—Doxorubicin—ovarian cancer	3.8e-05	0.000596	CcSEcCtD
Vinorelbine—Dysphagia—Epirubicin—ovarian cancer	3.79e-05	0.000594	CcSEcCtD
Vinorelbine—Back pain—Docetaxel—ovarian cancer	3.78e-05	0.000593	CcSEcCtD
Vinorelbine—Anaphylactic shock—Paclitaxel—ovarian cancer	3.77e-05	0.000591	CcSEcCtD
Vinorelbine—Infection—Paclitaxel—ovarian cancer	3.74e-05	0.000587	CcSEcCtD
Vinorelbine—Pancreatitis—Epirubicin—ovarian cancer	3.71e-05	0.000582	CcSEcCtD
Vinorelbine—Nervous system disorder—Paclitaxel—ovarian cancer	3.69e-05	0.000579	CcSEcCtD
Vinorelbine—Angina pectoris—Epirubicin—ovarian cancer	3.69e-05	0.000578	CcSEcCtD
Vinorelbine—Thrombocytopenia—Paclitaxel—ovarian cancer	3.69e-05	0.000578	CcSEcCtD
Vinorelbine—Tachycardia—Paclitaxel—ovarian cancer	3.68e-05	0.000576	CcSEcCtD
Vinorelbine—Skin disorder—Paclitaxel—ovarian cancer	3.66e-05	0.000574	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	3.65e-05	0.000572	CcSEcCtD
Vinorelbine—Anaemia—Docetaxel—ovarian cancer	3.62e-05	0.000567	CcSEcCtD
Vinorelbine—Pancytopenia—Epirubicin—ovarian cancer	3.6e-05	0.000564	CcSEcCtD
Vinorelbine—Anorexia—Paclitaxel—ovarian cancer	3.59e-05	0.000563	CcSEcCtD
Vinorelbine—Muscular weakness—Doxorubicin—ovarian cancer	3.58e-05	0.000561	CcSEcCtD
Vinorelbine—Neutropenia—Epirubicin—ovarian cancer	3.54e-05	0.000555	CcSEcCtD
Vinorelbine—Hypotension—Paclitaxel—ovarian cancer	3.52e-05	0.000552	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—ovarian cancer	3.5e-05	0.000549	CcSEcCtD
Vinorelbine—Leukopenia—Docetaxel—ovarian cancer	3.5e-05	0.000549	CcSEcCtD
Vinorelbine—Palpitations—Docetaxel—ovarian cancer	3.46e-05	0.000542	CcSEcCtD
Vinorelbine—Pancreatitis—Doxorubicin—ovarian cancer	3.43e-05	0.000539	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	3.43e-05	0.000538	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—SKP2—ovarian cancer	3.43e-05	0.00107	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.43e-05	0.00107	CbGpPWpGaD
Vinorelbine—Weight decreased—Epirubicin—ovarian cancer	3.43e-05	0.000537	CcSEcCtD
Vinorelbine—Cough—Docetaxel—ovarian cancer	3.41e-05	0.000535	CcSEcCtD
Vinorelbine—Angina pectoris—Doxorubicin—ovarian cancer	3.41e-05	0.000535	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—TUBB3—ovarian cancer	3.4e-05	0.00106	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—TUBB3—ovarian cancer	3.4e-05	0.00106	CbGpPWpGaD
Vinorelbine—Pneumonia—Epirubicin—ovarian cancer	3.4e-05	0.000533	CcSEcCtD
Vinorelbine—Paraesthesia—Paclitaxel—ovarian cancer	3.38e-05	0.00053	CcSEcCtD
Vinorelbine—Hypertension—Docetaxel—ovarian cancer	3.38e-05	0.00053	CcSEcCtD
Vinorelbine—Infestation NOS—Epirubicin—ovarian cancer	3.38e-05	0.000529	CcSEcCtD
Vinorelbine—Infestation—Epirubicin—ovarian cancer	3.38e-05	0.000529	CcSEcCtD
Vinorelbine—Dyspnoea—Paclitaxel—ovarian cancer	3.36e-05	0.000527	CcSEcCtD
Vinorelbine—Chest pain—Docetaxel—ovarian cancer	3.33e-05	0.000522	CcSEcCtD
Vinorelbine—Arthralgia—Docetaxel—ovarian cancer	3.33e-05	0.000522	CcSEcCtD
Vinorelbine—Myalgia—Docetaxel—ovarian cancer	3.33e-05	0.000522	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—ovarian cancer	3.33e-05	0.000522	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Epirubicin—ovarian cancer	3.31e-05	0.000519	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	3.31e-05	0.000519	CcSEcCtD
Vinorelbine—Stomatitis—Epirubicin—ovarian cancer	3.29e-05	0.000516	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—ovarian cancer	3.28e-05	0.000514	CcSEcCtD
Vinorelbine—Decreased appetite—Paclitaxel—ovarian cancer	3.27e-05	0.000513	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	3.25e-05	0.00051	CcSEcCtD
Vinorelbine—Fatigue—Paclitaxel—ovarian cancer	3.25e-05	0.000509	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—ovarian cancer	3.25e-05	0.00101	CbGpPWpGaD
Vinorelbine—Pain—Paclitaxel—ovarian cancer	3.22e-05	0.000505	CcSEcCtD
Vinorelbine—Constipation—Paclitaxel—ovarian cancer	3.22e-05	0.000505	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Epirubicin—ovarian cancer	3.19e-05	0.000501	CcSEcCtD
Vinorelbine—Anaphylactic shock—Docetaxel—ovarian cancer	3.19e-05	0.000501	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—TUBB3—ovarian cancer	3.18e-05	0.000993	CbGpPWpGaD
Vinorelbine—Infection—Docetaxel—ovarian cancer	3.17e-05	0.000497	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—ovarian cancer	3.17e-05	0.000497	CcSEcCtD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	3.17e-05	0.000987	CbGpPWpGaD
Vinorelbine—Agranulocytosis—Epirubicin—ovarian cancer	3.15e-05	0.000494	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—ovarian cancer	3.14e-05	0.000493	CcSEcCtD
Vinorelbine—Nervous system disorder—Docetaxel—ovarian cancer	3.13e-05	0.000491	CcSEcCtD
Vinorelbine—Thrombocytopenia—Docetaxel—ovarian cancer	3.13e-05	0.00049	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—ovarian cancer	3.12e-05	0.00049	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—ovarian cancer	3.12e-05	0.00049	CcSEcCtD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	3.12e-05	0.000974	CbGpPWpGaD
Vinorelbine—Tachycardia—Docetaxel—ovarian cancer	3.12e-05	0.000489	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—TUBB3—ovarian cancer	3.11e-05	0.000971	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Paclitaxel—ovarian cancer	3.1e-05	0.000487	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—MLH1—ovarian cancer	3.1e-05	0.000968	CbGpPWpGaD
Vinorelbine—Skin disorder—Docetaxel—ovarian cancer	3.1e-05	0.000486	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Paclitaxel—ovarian cancer	3.08e-05	0.000483	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.08e-05	0.000959	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—SKP2—ovarian cancer	3.07e-05	0.000957	CbGpPWpGaD
Vinorelbine—Neuropathy peripheral—Doxorubicin—ovarian cancer	3.06e-05	0.00048	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	3.06e-05	0.000953	CbGpPWpGaD
Vinorelbine—Stomatitis—Doxorubicin—ovarian cancer	3.04e-05	0.000478	CcSEcCtD
Vinorelbine—Anorexia—Docetaxel—ovarian cancer	3.04e-05	0.000477	CcSEcCtD
Vinorelbine—Hypoaesthesia—Epirubicin—ovarian cancer	3.02e-05	0.000473	CcSEcCtD
Vinorelbine—Urticaria—Paclitaxel—ovarian cancer	2.99e-05	0.000469	CcSEcCtD
Vinorelbine—Hypotension—Docetaxel—ovarian cancer	2.98e-05	0.000468	CcSEcCtD
Vinorelbine—Connective tissue disorder—Epirubicin—ovarian cancer	2.98e-05	0.000467	CcSEcCtD
Vinorelbine—Body temperature increased—Paclitaxel—ovarian cancer	2.98e-05	0.000467	CcSEcCtD
Vinorelbine—Abdominal pain—Paclitaxel—ovarian cancer	2.98e-05	0.000467	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—ovarian cancer	2.95e-05	0.000463	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—ovarian cancer	2.92e-05	0.000457	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	2.91e-05	0.000456	CcSEcCtD
Vinorelbine—TUBB2B—Metabolism of proteins—ATF3—ovarian cancer	2.87e-05	0.000896	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—ATF3—ovarian cancer	2.87e-05	0.000896	CbGpPWpGaD
Vinorelbine—Paraesthesia—Docetaxel—ovarian cancer	2.87e-05	0.00045	CcSEcCtD
Vinorelbine—Dyspnoea—Docetaxel—ovarian cancer	2.85e-05	0.000446	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—SKP2—ovarian cancer	2.84e-05	0.000887	CbGpPWpGaD
Vinorelbine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	2.82e-05	0.000879	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.81e-05	0.000878	CbGpPWpGaD
Vinorelbine—Cardiac disorder—Epirubicin—ovarian cancer	2.81e-05	0.000441	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—ovarian cancer	2.81e-05	0.000441	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—TUBB3—ovarian cancer	2.8e-05	0.000872	CbGpPWpGaD
Vinorelbine—Hypoaesthesia—Doxorubicin—ovarian cancer	2.79e-05	0.000438	CcSEcCtD
Vinorelbine—Decreased appetite—Docetaxel—ovarian cancer	2.78e-05	0.000435	CcSEcCtD
Vinorelbine—Hypersensitivity—Paclitaxel—ovarian cancer	2.77e-05	0.000435	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—ATF3—ovarian cancer	2.77e-05	0.000866	CbGpPWpGaD
Vinorelbine—Gastrointestinal disorder—Docetaxel—ovarian cancer	2.76e-05	0.000432	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—ovarian cancer	2.76e-05	0.000432	CcSEcCtD
Vinorelbine—Fatigue—Docetaxel—ovarian cancer	2.75e-05	0.000432	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—ovarian cancer	2.75e-05	0.000431	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—ovarian cancer	2.74e-05	0.000429	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—ovarian cancer	2.73e-05	0.000428	CcSEcCtD
Vinorelbine—Constipation—Docetaxel—ovarian cancer	2.73e-05	0.000428	CcSEcCtD
Vinorelbine—Pain—Docetaxel—ovarian cancer	2.73e-05	0.000428	CcSEcCtD
Vinorelbine—Arrhythmia—Epirubicin—ovarian cancer	2.71e-05	0.000425	CcSEcCtD
Vinorelbine—Asthenia—Paclitaxel—ovarian cancer	2.7e-05	0.000424	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—ATF3—ovarian cancer	2.69e-05	0.000838	CbGpPWpGaD
Vinorelbine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	2.68e-05	0.000837	CbGpPWpGaD
Vinorelbine—Alopecia—Epirubicin—ovarian cancer	2.68e-05	0.00042	CcSEcCtD
Vinorelbine—Pruritus—Paclitaxel—ovarian cancer	2.66e-05	0.000418	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—ovarian cancer	2.64e-05	0.000414	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—ovarian cancer	2.64e-05	0.000414	CcSEcCtD
Vinorelbine—Feeling abnormal—Docetaxel—ovarian cancer	2.63e-05	0.000413	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND2—ovarian cancer	2.63e-05	0.00082	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—ATF3—ovarian cancer	2.63e-05	0.00082	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Docetaxel—ovarian cancer	2.61e-05	0.000409	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—ovarian cancer	2.6e-05	0.000408	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—ovarian cancer	2.6e-05	0.000408	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—SKP2—ovarian cancer	2.6e-05	0.000811	CbGpPWpGaD
Vinorelbine—Diarrhoea—Paclitaxel—ovarian cancer	2.58e-05	0.000404	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—MLH1—ovarian cancer	2.57e-05	0.000802	CbGpPWpGaD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	2.57e-05	0.0008	CbGpPWpGaD
Vinorelbine—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	2.56e-05	0.000798	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—TUBB3—ovarian cancer	2.56e-05	0.000797	CbGpPWpGaD
Vinorelbine—Back pain—Epirubicin—ovarian cancer	2.55e-05	0.0004	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—ovarian cancer	2.54e-05	0.000399	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—SKP2—ovarian cancer	2.54e-05	0.000793	CbGpPWpGaD
Vinorelbine—Immune system disorder—Doxorubicin—ovarian cancer	2.53e-05	0.000397	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—ovarian cancer	2.53e-05	0.000396	CcSEcCtD
Vinorelbine—Abdominal pain—Docetaxel—ovarian cancer	2.52e-05	0.000396	CcSEcCtD
Vinorelbine—Body temperature increased—Docetaxel—ovarian cancer	2.52e-05	0.000396	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—CHEK2—ovarian cancer	2.51e-05	0.000782	CbGpPWpGaD
Vinorelbine—Arrhythmia—Doxorubicin—ovarian cancer	2.51e-05	0.000393	CcSEcCtD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.5e-05	0.00078	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.5e-05	0.00078	CbGpPWpGaD
Vinorelbine—Dizziness—Paclitaxel—ovarian cancer	2.49e-05	0.000391	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	2.48e-05	0.000774	CbGpPWpGaD
Vinorelbine—Alopecia—Doxorubicin—ovarian cancer	2.48e-05	0.000389	CcSEcCtD
Vinorelbine—Ill-defined disorder—Epirubicin—ovarian cancer	2.45e-05	0.000384	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—ovarian cancer	2.44e-05	0.000383	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—ovarian cancer	2.44e-05	0.000383	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—ovarian cancer	2.44e-05	0.000382	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.41e-05	0.000753	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.41e-05	0.000753	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.41e-05	0.000753	CbGpPWpGaD
Vinorelbine—Vomiting—Paclitaxel—ovarian cancer	2.39e-05	0.000376	CcSEcCtD
Vinorelbine—Malaise—Epirubicin—ovarian cancer	2.38e-05	0.000373	CcSEcCtD
Vinorelbine—Rash—Paclitaxel—ovarian cancer	2.37e-05	0.000372	CcSEcCtD
Vinorelbine—Dermatitis—Paclitaxel—ovarian cancer	2.37e-05	0.000372	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—ovarian cancer	2.37e-05	0.000372	CcSEcCtD
Vinorelbine—Leukopenia—Epirubicin—ovarian cancer	2.36e-05	0.00037	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—ovarian cancer	2.36e-05	0.00037	CcSEcCtD
Vinorelbine—Headache—Paclitaxel—ovarian cancer	2.36e-05	0.00037	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—ATF3—ovarian cancer	2.36e-05	0.000736	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Docetaxel—ovarian cancer	2.35e-05	0.000369	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—CCND2—ovarian cancer	2.35e-05	0.000733	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—BRCA1—ovarian cancer	2.35e-05	0.000733	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MLH1—ovarian cancer	2.35e-05	0.000733	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.34e-05	0.000729	CbGpPWpGaD
Vinorelbine—Palpitations—Epirubicin—ovarian cancer	2.33e-05	0.000366	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.33e-05	0.000727	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—SKP2—ovarian cancer	2.32e-05	0.000725	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCNE1—ovarian cancer	2.3e-05	0.000718	CbGpPWpGaD
Vinorelbine—Cough—Epirubicin—ovarian cancer	2.3e-05	0.000361	CcSEcCtD
Vinorelbine—Asthenia—Docetaxel—ovarian cancer	2.29e-05	0.000359	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.29e-05	0.000713	CbGpPWpGaD
Vinorelbine—Hypertension—Epirubicin—ovarian cancer	2.28e-05	0.000357	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—ovarian cancer	2.26e-05	0.000355	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—TYMS—ovarian cancer	2.26e-05	0.000705	CbGpPWpGaD
Vinorelbine—Pruritus—Docetaxel—ovarian cancer	2.26e-05	0.000354	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.26e-05	0.000704	CbGpPWpGaD
Vinorelbine—Anaemia—Doxorubicin—ovarian cancer	2.26e-05	0.000354	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—ovarian cancer	2.25e-05	0.000352	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—ovarian cancer	2.25e-05	0.000352	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—ovarian cancer	2.25e-05	0.000352	CcSEcCtD
Vinorelbine—Nausea—Paclitaxel—ovarian cancer	2.24e-05	0.000351	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	2.23e-05	0.00035	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—ovarian cancer	2.22e-05	0.000348	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—PPP2R1A—ovarian cancer	2.22e-05	0.000692	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.21e-05	0.000689	CbGpPWpGaD
Vinorelbine—Malaise—Doxorubicin—ovarian cancer	2.2e-05	0.000345	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—ovarian cancer	2.19e-05	0.000344	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	2.19e-05	0.000684	CbGpPWpGaD
Vinorelbine—Leukopenia—Doxorubicin—ovarian cancer	2.19e-05	0.000343	CcSEcCtD
Vinorelbine—Diarrhoea—Docetaxel—ovarian cancer	2.18e-05	0.000343	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND2—ovarian cancer	2.18e-05	0.000679	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—ATF3—ovarian cancer	2.16e-05	0.000673	CbGpPWpGaD
Vinorelbine—Palpitations—Doxorubicin—ovarian cancer	2.16e-05	0.000338	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—ovarian cancer	2.15e-05	0.000338	CcSEcCtD
Vinorelbine—Infection—Epirubicin—ovarian cancer	2.14e-05	0.000335	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—ovarian cancer	2.13e-05	0.000334	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—BRCA2—ovarian cancer	2.13e-05	0.000663	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Epirubicin—ovarian cancer	2.11e-05	0.000331	CcSEcCtD
Vinorelbine—Dizziness—Docetaxel—ovarian cancer	2.11e-05	0.000331	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—ovarian cancer	2.11e-05	0.000331	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—ovarian cancer	2.11e-05	0.000331	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—ovarian cancer	2.1e-05	0.00033	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—ovarian cancer	2.09e-05	0.000328	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—CHEK2—ovarian cancer	2.08e-05	0.000648	CbGpPWpGaD
Vinorelbine—Myalgia—Doxorubicin—ovarian cancer	2.08e-05	0.000326	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—ovarian cancer	2.08e-05	0.000326	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—ovarian cancer	2.08e-05	0.000326	CcSEcCtD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	2.07e-05	0.000646	CbGpPWpGaD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	2.06e-05	0.000324	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—CCNE1—ovarian cancer	2.06e-05	0.000642	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	2.05e-05	0.000641	CbGpPWpGaD
Vinorelbine—Discomfort—Doxorubicin—ovarian cancer	2.05e-05	0.000322	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—ovarian cancer	2.05e-05	0.000322	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.05e-05	0.00064	CbGpPWpGaD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	2.04e-05	0.000637	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—BIRC5—ovarian cancer	2.03e-05	0.000634	CbGpPWpGaD
Vinorelbine—Vomiting—Docetaxel—ovarian cancer	2.03e-05	0.000318	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—TYMS—ovarian cancer	2.02e-05	0.000631	CbGpPWpGaD
Vinorelbine—Rash—Docetaxel—ovarian cancer	2.01e-05	0.000316	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—ovarian cancer	2.01e-05	0.000316	CcSEcCtD
Vinorelbine—Dermatitis—Docetaxel—ovarian cancer	2.01e-05	0.000315	CcSEcCtD
Vinorelbine—Headache—Docetaxel—ovarian cancer	2e-05	0.000314	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND2—ovarian cancer	1.99e-05	0.000621	CbGpPWpGaD
Vinorelbine—Anaphylactic shock—Doxorubicin—ovarian cancer	1.99e-05	0.000312	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.98e-05	0.000618	CbGpPWpGaD
Vinorelbine—Infection—Doxorubicin—ovarian cancer	1.98e-05	0.00031	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	1.96e-05	0.000308	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—ovarian cancer	1.95e-05	0.000306	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—ovarian cancer	1.95e-05	0.000306	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—CCND2—ovarian cancer	1.95e-05	0.000608	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—BRCA1—ovarian cancer	1.95e-05	0.000608	CbGpPWpGaD
Vinorelbine—Tachycardia—Doxorubicin—ovarian cancer	1.94e-05	0.000305	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—ovarian cancer	1.94e-05	0.000303	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—ovarian cancer	1.93e-05	0.000303	CcSEcCtD
Vinorelbine—Dyspnoea—Epirubicin—ovarian cancer	1.92e-05	0.000301	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	1.91e-05	0.000595	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.91e-05	0.000594	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.91e-05	0.000594	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CHEK2—ovarian cancer	1.9e-05	0.000593	CbGpPWpGaD
Vinorelbine—Anorexia—Doxorubicin—ovarian cancer	1.9e-05	0.000298	CcSEcCtD
Vinorelbine—Nausea—Docetaxel—ovarian cancer	1.9e-05	0.000297	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	1.88e-05	0.000586	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.88e-05	0.000586	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—TYMS—ovarian cancer	1.87e-05	0.000585	CbGpPWpGaD
Vinorelbine—Decreased appetite—Epirubicin—ovarian cancer	1.87e-05	0.000294	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—ovarian cancer	1.86e-05	0.000292	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—ovarian cancer	1.86e-05	0.000292	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—ovarian cancer	1.86e-05	0.000291	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—ovarian cancer	1.84e-05	0.000289	CcSEcCtD
Vinorelbine—Pain—Epirubicin—ovarian cancer	1.84e-05	0.000289	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.84e-05	0.000574	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—PPP2R1A—ovarian cancer	1.84e-05	0.000573	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—BIRC5—ovarian cancer	1.82e-05	0.000567	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	1.82e-05	0.000285	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.81e-05	0.000565	CbGpPWpGaD
Vinorelbine—Paraesthesia—Doxorubicin—ovarian cancer	1.79e-05	0.000281	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.78e-05	0.000556	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND2—ovarian cancer	1.78e-05	0.000556	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—BRCA1—ovarian cancer	1.78e-05	0.000556	CbGpPWpGaD
Vinorelbine—Dyspnoea—Doxorubicin—ovarian cancer	1.78e-05	0.000279	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—ovarian cancer	1.77e-05	0.000278	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—BRCA2—ovarian cancer	1.76e-05	0.000549	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TERT—ovarian cancer	1.76e-05	0.000549	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Epirubicin—ovarian cancer	1.76e-05	0.000276	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCNE1—ovarian cancer	1.75e-05	0.000544	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.74e-05	0.000544	CbGpPWpGaD
Vinorelbine—Decreased appetite—Doxorubicin—ovarian cancer	1.73e-05	0.000272	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	1.72e-05	0.00027	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—ovarian cancer	1.72e-05	0.000269	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—TYMS—ovarian cancer	1.71e-05	0.000535	CbGpPWpGaD
Vinorelbine—Urticaria—Epirubicin—ovarian cancer	1.71e-05	0.000268	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—CCNE1—ovarian cancer	1.71e-05	0.000532	CbGpPWpGaD
Vinorelbine—Pain—Doxorubicin—ovarian cancer	1.7e-05	0.000267	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—ovarian cancer	1.7e-05	0.000267	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—ovarian cancer	1.7e-05	0.000267	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—ovarian cancer	1.7e-05	0.000267	CcSEcCtD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	1.69e-05	0.000526	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	1.69e-05	0.000526	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—PPP2R1A—ovarian cancer	1.68e-05	0.000524	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	1.68e-05	0.000523	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TYMS—ovarian cancer	1.68e-05	0.000523	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Doxorubicin—ovarian cancer	1.64e-05	0.000257	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—ovarian cancer	1.63e-05	0.000255	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—BRCA2—ovarian cancer	1.61e-05	0.000503	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Epirubicin—ovarian cancer	1.59e-05	0.000249	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—ovarian cancer	1.58e-05	0.000248	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—ovarian cancer	1.57e-05	0.000247	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—ovarian cancer	1.57e-05	0.000247	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.56e-05	0.000488	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCNE1—ovarian cancer	1.56e-05	0.000487	CbGpPWpGaD
Vinorelbine—Asthenia—Epirubicin—ovarian cancer	1.54e-05	0.000242	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—BIRC5—ovarian cancer	1.54e-05	0.000481	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TYMS—ovarian cancer	1.53e-05	0.000478	CbGpPWpGaD
Vinorelbine—Pruritus—Epirubicin—ovarian cancer	1.52e-05	0.000239	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—BIRC5—ovarian cancer	1.51e-05	0.00047	CbGpPWpGaD
Vinorelbine—Diarrhoea—Epirubicin—ovarian cancer	1.47e-05	0.000231	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—ovarian cancer	1.47e-05	0.00023	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	1.46e-05	0.000456	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TERT—ovarian cancer	1.46e-05	0.000455	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.43e-05	0.000446	CbGpPWpGaD
Vinorelbine—Asthenia—Doxorubicin—ovarian cancer	1.43e-05	0.000224	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—ovarian cancer	1.42e-05	0.000223	CcSEcCtD
Vinorelbine—Pruritus—Doxorubicin—ovarian cancer	1.41e-05	0.000221	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—BIRC5—ovarian cancer	1.38e-05	0.00043	CbGpPWpGaD
Vinorelbine—Vomiting—Epirubicin—ovarian cancer	1.37e-05	0.000215	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—ovarian cancer	1.36e-05	0.000214	CcSEcCtD
Vinorelbine—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	1.36e-05	0.000425	CbGpPWpGaD
Vinorelbine—Rash—Epirubicin—ovarian cancer	1.36e-05	0.000213	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—ovarian cancer	1.36e-05	0.000213	CcSEcCtD
Vinorelbine—Headache—Epirubicin—ovarian cancer	1.35e-05	0.000212	CcSEcCtD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	1.34e-05	0.000419	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TERT—ovarian cancer	1.33e-05	0.000416	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	1.33e-05	0.000416	CbGpPWpGaD
Vinorelbine—Dizziness—Doxorubicin—ovarian cancer	1.32e-05	0.000207	CcSEcCtD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	1.29e-05	0.000402	CbGpPWpGaD
Vinorelbine—Nausea—Epirubicin—ovarian cancer	1.28e-05	0.000201	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—ovarian cancer	1.27e-05	0.000199	CcSEcCtD
Vinorelbine—Rash—Doxorubicin—ovarian cancer	1.26e-05	0.000197	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—ovarian cancer	1.25e-05	0.000197	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	1.25e-05	0.00039	CbGpPWpGaD
Vinorelbine—Headache—Doxorubicin—ovarian cancer	1.25e-05	0.000196	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	1.19e-05	0.000372	CbGpPWpGaD
Vinorelbine—Nausea—Doxorubicin—ovarian cancer	1.18e-05	0.000186	CcSEcCtD
Vinorelbine—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	1.18e-05	0.000368	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND1—ovarian cancer	1.14e-05	0.000355	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	1.13e-05	0.000353	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	1.13e-05	0.000352	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CASP3—ovarian cancer	1.13e-05	0.000352	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL2—ovarian cancer	1.13e-05	0.000351	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—MMP2—ovarian cancer	1.11e-05	0.000345	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MMP2—ovarian cancer	1.11e-05	0.000345	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	1.1e-05	0.000345	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	1.1e-05	0.000342	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	1.08e-05	0.000337	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	1.08e-05	0.000336	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—MMP2—ovarian cancer	1.07e-05	0.000333	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN1B—ovarian cancer	1.07e-05	0.000333	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—MMP2—ovarian cancer	1.03e-05	0.000323	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND1—ovarian cancer	1.02e-05	0.000318	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MMP2—ovarian cancer	1.01e-05	0.000316	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	9.89e-06	0.000308	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	9.57e-06	0.000298	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND1—ovarian cancer	9.43e-06	0.000294	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MAPK3—ovarian cancer	9.39e-06	0.000293	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CXCL8—ovarian cancer	9.19e-06	0.000287	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CXCL8—ovarian cancer	9.19e-06	0.000287	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MYC—ovarian cancer	9.13e-06	0.000285	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—MMP2—ovarian cancer	9.08e-06	0.000283	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	9.05e-06	0.000282	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MAPK1—ovarian cancer	8.93e-06	0.000279	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	8.91e-06	0.000278	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CXCL8—ovarian cancer	8.88e-06	0.000277	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1B—ovarian cancer	8.84e-06	0.000276	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NME2—ovarian cancer	8.82e-06	0.000275	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	8.79e-06	0.000274	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND1—ovarian cancer	8.63e-06	0.000269	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CXCL8—ovarian cancer	8.6e-06	0.000268	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.55e-06	0.000267	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CTNNB1—ovarian cancer	8.48e-06	0.000265	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CTNNB1—ovarian cancer	8.48e-06	0.000265	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND1—ovarian cancer	8.44e-06	0.000263	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CXCL8—ovarian cancer	8.41e-06	0.000262	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MAPK3—ovarian cancer	8.4e-06	0.000262	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	8.35e-06	0.000261	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NME2—ovarian cancer	8.31e-06	0.000259	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—MMP2—ovarian cancer	8.31e-06	0.000259	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CTNNB1—ovarian cancer	8.19e-06	0.000255	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYC—ovarian cancer	8.17e-06	0.000255	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1B—ovarian cancer	8.09e-06	0.000252	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MAPK1—ovarian cancer	7.99e-06	0.000249	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CTNNB1—ovarian cancer	7.93e-06	0.000247	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	7.9e-06	0.000246	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	7.78e-06	0.000243	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CTNNB1—ovarian cancer	7.76e-06	0.000242	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND1—ovarian cancer	7.72e-06	0.000241	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYC—ovarian cancer	7.57e-06	0.000236	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CXCL8—ovarian cancer	7.55e-06	0.000235	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	7.4e-06	0.000231	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MAPK3—ovarian cancer	7.12e-06	0.000222	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	7.05e-06	0.00022	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CTNNB1—ovarian cancer	6.96e-06	0.000217	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MAPK3—ovarian cancer	6.96e-06	0.000217	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYC—ovarian cancer	6.92e-06	0.000216	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CXCL8—ovarian cancer	6.9e-06	0.000215	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MAPK1—ovarian cancer	6.77e-06	0.000211	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYC—ovarian cancer	6.77e-06	0.000211	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—ovarian cancer	6.71e-06	0.000209	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MAPK1—ovarian cancer	6.62e-06	0.000206	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CTNNB1—ovarian cancer	6.37e-06	0.000199	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MAPK3—ovarian cancer	6.36e-06	0.000198	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYC—ovarian cancer	6.19e-06	0.000193	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	6.13e-06	0.000191	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MAPK1—ovarian cancer	6.05e-06	0.000189	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.7e-06	0.000178	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYTB—ovarian cancer	5.68e-06	0.000177	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	5.68e-06	0.000177	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	5.56e-06	0.000174	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—ovarian cancer	5.56e-06	0.000173	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.51e-06	0.000172	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NME2—ovarian cancer	5.43e-06	0.000169	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	5.42e-06	0.000169	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	5.36e-06	0.000167	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYTB—ovarian cancer	5.36e-06	0.000167	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	5.23e-06	0.000163	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—ovarian cancer	5.08e-06	0.000159	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPP1CC—ovarian cancer	4.97e-06	0.000155	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—BRIP1—ovarian cancer	4.97e-06	0.000155	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	4.72e-06	0.000147	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	4.68e-06	0.000146	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—BRIP1—ovarian cancer	4.68e-06	0.000146	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	4.47e-06	0.000139	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	4.34e-06	0.000136	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	4.25e-06	0.000133	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	4.25e-06	0.000133	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	4.01e-06	0.000125	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	3.69e-06	0.000115	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	3.57e-06	0.000111	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYTB—ovarian cancer	3.5e-06	0.000109	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—YAP1—ovarian cancer	3.33e-06	0.000104	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—YAP1—ovarian cancer	3.14e-06	9.79e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—BRIP1—ovarian cancer	3.06e-06	9.55e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	3.06e-06	9.55e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.01e-06	9.4e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—FASN—ovarian cancer	2.72e-06	8.47e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC5A5—ovarian cancer	2.67e-06	8.33e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC2A1—ovarian cancer	2.58e-06	8.05e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—FASN—ovarian cancer	2.56e-06	7.98e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	2.52e-06	7.85e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1B1—ovarian cancer	2.47e-06	7.72e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	2.43e-06	7.58e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	2.33e-06	7.27e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	2.19e-06	6.84e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	2.07e-06	6.45e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—YAP1—ovarian cancer	2.05e-06	6.4e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TYMS—ovarian cancer	2e-06	6.24e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCB1—ovarian cancer	1.92e-06	5.99e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TYMS—ovarian cancer	1.89e-06	5.88e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—FASN—ovarian cancer	1.67e-06	5.22e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.65e-06	5.13e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CAV1—ovarian cancer	1.61e-06	5.03e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.59e-06	4.96e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.52e-06	4.75e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CAV1—ovarian cancer	1.52e-06	4.74e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CG—ovarian cancer	1.47e-06	4.58e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.38e-06	4.32e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.35e-06	4.22e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CD—ovarian cancer	1.29e-06	4.03e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.26e-06	3.91e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TYMS—ovarian cancer	1.23e-06	3.84e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.22e-06	3.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.13e-06	3.51e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.06e-06	3.31e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CAV1—ovarian cancer	9.93e-07	3.1e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTEN—ovarian cancer	9.72e-07	3.03e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTEN—ovarian cancer	9.16e-07	2.86e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	9.05e-07	2.82e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	7.95e-07	2.48e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	6.93e-07	2.16e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CA—ovarian cancer	6.86e-07	2.14e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	6.46e-07	2.02e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTEN—ovarian cancer	5.99e-07	1.87e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKT1—ovarian cancer	5.6e-07	1.75e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKT1—ovarian cancer	5.28e-07	1.65e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	4.23e-07	1.32e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKT1—ovarian cancer	3.45e-07	1.08e-05	CbGpPWpGaD
